Fig. 3: ATP1A1 inhibits the proliferation of ccRCC in vivo. | Cancer Gene Therapy

Fig. 3: ATP1A1 inhibits the proliferation of ccRCC in vivo.

From: pNaktide reverses metabolic reprogramming and disease progression of ATP1A1-deficiency clear cell renal cell carcinoma

Fig. 3

A A representative image of tumor growth in nude mice subcutaneously inoculated with 769-P cells that overexpress ATP1A1. B The tumor-growth curve for nude mice that were subcutaneously injected with 769-P cells overexpressing ATP1A1, with tumor sizes measured every 3 days over a period of 4 weeks. C Tumor weights were collected from the post-sacrifice subcutaneous mouse model. D IHC analysis of Ki67 shows a decreased proportion of Ki67-positive cells in tumors derived from ATP1A1-overexpressing cells. *P < 0.05; **P < 0.01.

Back to article page